Moreover, AAV-mediated delivery of an antibody targeting the interaction of TDP-43 with p65 NF-κB reduced NF-κB activation and TDP-43 pathology in mouse models of ALS/FTD [10]. Here, NFKB1 is linked to amyotrophic lateral sclerosis.